ACKGROUND: Klepsiella pneumoniae, one of clinical isolates, is frequently found causative agent of hospital acquired infection. Currently, K. pneumoniae is found as extended-Spectrum β-lactamases (ESBL) producer, allowing it to become multidrugresistant. A clinical laboratory with limited facility needs a valid, reliable, inexpensive and simple laboratory test to control its infection and antimicrobial-resistancy. The aim of this study is to evaluate the diagnostic performance of a ESBL media to detect ESBL-producing K. pneumoniae.
Introduction
In developing countries, infectious diseases remain as the first cause of illness in community. Treatments for infections usually involve antibiotics. With many advances in technology, the number and type of clinically useful antibiotics is increasing. Inappropriate antibiotic treatment may result adverse effects, such as the emergence of bacterial resistance and low antibiotic efficacy against certain bacteria. Bacterial resistance against antibiotics are a current global issue. (1) Resistance against antibiotics is mostly caused by nosocomial infections. Klebsiella spp. are important pathogenic bacteria causing nosocomial infections. Generally, Klebsiella spp. infections are implicated in pneumonia, urinary tractus infections, meningitis and septicemia. The increasing resistancy of Klebsiella spp. has been widely reported as the effect of enzymes extended-spectrum β-lactamases (ESBL) and Klebsiella pneumoniae carbapenemase (KCP). (2) ESBL is an enzyme that hydrolyze penicillin, cephalosporin (first, second, third generations), oxymino-β-lactam compound (aztreonam, but not cephamycin and carbapenem) and may be inhibited by β-lactamase inhibitor (clavulanate, sulbactam and tazobactam). (3) Various screening and confirmation tests have been developed to detect ESBL-producing K. pneumoniae. However, the increasing diversity of ESBL-producing K. pneumoniae strains, along with resistance mechanism of non-ESBL-producing K. pneumoniae, making identification of ESBL-producing K. pneumoniae by conventional phenotypic techniques difficult.(4) Double Disc Synergy Test (DDST) is able to find the phenotypic character profile of ESBL resistance against third generation cephalosporin (ceftazidim, cefpodoxime, ceftriaxone) and monobactams (aztreonam). The presence of ESBL-producing bacteria was indicated by an increase in inhibitory zone on amoxicillin/ clavulanic acid through third-generation cephalosporins. (5) There was a breakthrough in the development of selective chromogenic medium for the screening of ESBL-producing K. pneumoniae directly from clinical specimens. Selectivity was provided based on colony color by chromogenic media.(6) New ESBL media with chromogenic medium has been developed. It contains nutrient rich media with a mixture of antibiotics, including cefpodoxime for detection of ESBL-bearing bacteria. (7) A study reported that the new ESBL media had a sensitivity of 88% and specificity of 94.4% in detecting ESBL-producing Enterobactericeae in 24 hours. (8) In detecting antimicrobial resistance, the role of routine laboratory services is very essential. Surveillance of bacterial pattern, antibiogram pattern, multiresistant bacterial detection is an important support for the treatment of patients with infections and reasonable antibiotic prescription. The objective of the study is to evaluate the sensitivity of new ESBL media with chromogenic medium in detecting ESBL-producing K. pneumoniae.
Methods
confirmatory test (9) and has sensitivity of 91.3% and specificity of 100%. (10) The clinical isolates of K. pneumoniae were obtained from urine, pus, blood, feces, sputum, cerebrospinal fluid, drain liquid, nasal sinus liquid, gastric wash, bronchi liquid, injury liquid and nasal swab. The clinical samples were inoculated on the appropriate media. After the growth was detected, identification of K. pneumoniae was performed using Vitek 2 System (bioMérieux).
The identified isolates of K. pneumoniae were inoculated on the ESBL media and incubated at 35°C for 18-24 hours, followed by observation and interpration. The growth of green colonies were interpretated as ESBLproducing K. pneumoniae.
DDST was performed by inoculating 0.5 McFarland turbidity standard of K. pneumoniae suspension on the Mueller Hinton solid media plate. After the suspension was dried, 30 µg ceftazidim, 30 µg cefotaxime, 30 µg cefepime and 20/10µg amoxycillin/clavulanic acid disc were added on the media. The media plates were incubated at 35°C for 18-24 hours. The presence/absence of an increase in inhibitory zone between β-lactam discs and β-lactam/β-lactamase inhibitor disc can be observed after the incubation.
K. pneumoniae ATCC 7000603 was used as the positive control of ESBL-producing bacteria, whereas Escherichia coli ATCC 25922 was used as the negative control of non-ESBL-producing bacteria. The results of ESBL media and DDST were intepreted by two observers.
The collected data were analyzed using decriptive statistic. Diagnostic performance was evaluated using 2x2 table. The sensitivity, specificity, accuracy, positive predictive value, negative predictive value, positive likelihood ratio and negative likelihood ratio were determined with 95% confidence interval.
The 
Results
A diagnostic test study using 103 clinical isolates of K. pneumoniae was conducted. In this study, the ChromID® ESBL media (bioMérieux, Marcy-l'Étoile, France) was used as the new ESBL media with chromogenic medium. The ESBL media was independently and blindly compared to the DDST, the gold standard test in detecting ESBLproducing K. pneumoniae. DDST is known as one of the Total number of K. pneumoniae isolates were 103, collected from patients with different ages, as shown in Table 1 . Sources of isolates were mostly urine (29.1%), pus (28.2%) and blood (22.3%). Urine specimens were collected from patients diagnosed with urinary tractus infection, chronic Result of new ESBL media and DDST were shown in Table 2 . DDST was able to detect 76 isolates of ESBLproducing K. pneumoniae (73.8%), whereas the ChromID® ESBL media was able to detect 83 isolates of ESBLproducing K. pneumoniae (80.6%). By using DDST as the standard, there were 9 samples with false positive and 2 samples with false negative results of new ESBL media. Table 3 showed the test characteristic of ChromID ESBL media in detecting the ESBL-producing K. pneumoniae. New ESBL media had high sensitivity (97.4%). The media also had positive (89.2%) and negative (90%) predictive value. renal failure, acute renal failure and kidney stones. Pus specimens were collected from patients diagnosed with diabetic ulcers, mandibula abscess, post laparotomy, colon abscess and nasal cavity carcinoma. The patients were mostly from non-intensive care without surgical treatment (59.2%). Meanwhile, 18.5% of patients were taken care in intensive care unit. Detail characteristics of isolates regarding age, source of isolates and their respective ward were shown in Table 1 .
Discussion
In this study, study subjects catagorized as elderly (≥ 55 years old) was 26.2%. Meanwhile previous study in hemodialysis patients whom suffered from bacteremia caused by K. pneumoniae reported that the proportion of patients older than 65 years old was 57.8%. (11) Another study reported that majority of study subjects (54.2%) whom suffered from K. pneumoniae bloodstream infections were aged more than 60 years. (12) Most of subjects in this study (68%) were from nonintensive care unit and only 18.5% were from the intensive care unit. A study in hemodialysis patients who also suffered from K. pneumoniae bacteremia, reported that 46.7% of subjects were from the intensive care unit. Another study reported that 67.9% of hospital-acquired K. pneumoniae infections were particularly among patients from neonatal intensive care unit, with mortality rate up to 70%. (13) Reglier-Poupet stated that longer incubation period of new ESBL media test may improve the sensitivity of this test. Negative results obtained from the new ESBL media can be improved with longer incubation. Incubation for 24 hours was associated with sensitivity of 88% and specificity of 94.4%. Meanwhile, incubation for 48 hours resulted in sensitivity of 94% and specificity of 90.5%. In the new ESBL media test with a reincubation period for 48 hours, colonies still did not grow, indicating no ESBL-producing In this study, there were 9 false positive results. These false positive results might be related with the antibiotic used in the new ESBL media test. There was only one type of antibiotic, cefpodoxime, while in DDST there were combinations of antibiotics including cefotaxime, amoxicilin, clavulanic acid. Therefore, false positive results could happened, whereas, shown as resistant results. The majority of ESBL enzymes, are different significantly in biochemical characteristics such as activity against specific β-lactam (e.g., cefotaxime, ceftazidime). (14) In false positive results, possibly there were non-Enterobacteriaceae isolates, Enterobacteriaceae strains with sefalosporinase, or penicillinase (Klebsiella oxytoca). The difficulty of the new ESBL media was to distinguish between ESBL-producing isolates and isolates that associated with other resistant mechanisms, i.e., strain mediated AmpC β-lactamase over production and strain with over production of β-lactamase in K. oxytoca. (8) The new ESBL media test could be used for screening patients with clinical presentation that indicating a high suspicious of ESBL-producing bacteria. The new ESBL media could be an appropriate method for monitoring critically ill patients with ESBL carrier. Low specificity in this study, suggested that all suspected ESBL-producing bacteria that were tested with the new ESBL media should be confirmed with a confirmation test, for example DDST. (15) In current study, this new ESBL media showed sensitivity of 97.4% and specifiicity of 66.7%. Another
